Drive Wealth Management LLC Increases Stake in Amazon.com, Inc. (NASDAQ:AMZN)
Drive Wealth Management LLC grew its position in Amazon.com, Inc. (NASDAQ:AMZN) by 3.9% during the 4th quarter, HoldingsChannel reports. The fund owned 30,855 shares of the e-commerce giant’s stock ...
Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $45.00 at Evercore ISI
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target hoisted by Evercore ISI from $33.00 to $45.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently ...
Vera plunges as Otsuka updates on rival therapy
Shares of Vera Therapeutics (NASDAQ:VERA) lost ~20% on Friday to reach a new 52-week low, in a move attributed to a potential market launch of a rival kidney disease therapy from Otsuka Holdings ...
CRISPR upped to outperform by Evercore on upcoming data
Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.
Fintel on MSN20h
Evercore ISI Group Upgrades CRISPR Therapeutics (CRSP)
Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
Evercore ISI analyst Liisa Bayko upgraded Crispr Therapeutics (CRSP) to Outperform from In Line with a price target of $99, up from $60.
PG&E price target lowered to $15 from $20 at Evercore ISI
Evercore ISI analyst Michael Lonegan lowered the firm’s price target on PG&E to $15 from $20 and keeps an In Line rating on the shares. The ...